Renal Globotriaosylceramide Deposits for Fabry Disease Linked to Uncertain Pathogenicity Gene Variant c.352C>T/p.Arg118Cys: A Family Study

Molecular genetics & genomic medicine - United States
doi 10.1002/mgg3.981
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Erratum To: Immunohistochemical Diagnosis of Fabry Nephropathy and Localisation of Globotriaosylceramide Deposits in Paraffin-Embedded Kidney Tissue Sections

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2012English

Prevalence of Fabry Disease and GLA C.196G>C Variant in Japanese Stroke Patients

Journal of Human Genetics
Genetics
2017English

'A Variant of Uncertain Significance' and the Proliferation of Human Disease Gene Databases

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2005English

Alpha-Galactosidase a p.A143T, a Non-Fabry Disease-Causing Variant

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2016English

A Liquid Chromatography-Quadrupole-Time-Of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse

Pharmaceutics
Pharmaceutical Science
2018English

Clinical Utility Gene Card For: Fabry Disease

European Journal of Human Genetics
Genetics
2011English

Renal Involvement in Fabry''s Disease

Internal Medicine
Internal MedicineMedicine
2000English

Progressive Podocyte Injury and Globotriaosylceramide (GL-3) Accumulation in Young Patients With Fabry Disease

Kidney International
Nephrology
2011English

Addressing Variant Pathogenicity: The TorsinA (TOR1A) Gene as a Model

Human Mutation
Genetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy